In a statement issued on June 4, 2023, in Mexico City, the Federal Commission for Protection against Health Risks(COFEPRIS – Federal Commission for the Protection against Sanitary Risks – Regulatory Agency of Mexico) reported that, according to the most recent Biweekly Therapeutic Expansion Report, authorizations have been granted for a total of 179 health inputs, encompassing the categories of drugs, medical devices, and clinical trials. One relevant clinical trial was conducted to evaluate a drug intended for the treatment of acute lymphoblastic leukemia. Read more here: bit.ly/3NdPG6e
ELS can help in the investigation and research of all types of medical devices in Europe and LATAM, please contact your local ELS consultant via this link: https://www.els-solutions.com/en/where-are-we/ or via email: info@elssolutions.pt
